or Try an Advanced Search...

    Technical Analysis for BTAI - BioXcel Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 2.01 -2.90% -0.06
    BTAI closed down 0.96 percent on Friday, May 17, 2024, on 1.67 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical BTAI trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion -2.90%
    Oversold Stochastic Weakness -2.90%
    Wide Bands Range Expansion -3.83%
    Gapped Up Strength -3.83%
    Oversold Stochastic Weakness -3.83%
    Wide Bands Range Expansion -2.43%
    Gapped Up Strength -2.43%
    Oversold Stochastic Weakness -2.43%
    Outside Day Range Expansion -5.64%
    Wide Bands Range Expansion -5.64%
    Older End-of-Day Signals for BTAI ...

       Recent Intraday Alerts

    Alert Time
    Down 3% 4 minutes ago
    60 Minute Opening Range Breakdown 11 minutes ago
    Down 2 % about 1 hour ago
    Down 1% about 2 hours ago
    Fell Below Previous Day's Low about 2 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    BTAI Chart by TradingView
    Basic chart:

    Profile

    BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company which is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Artificial Intelligence Neuroscience Drug Development Cybernetics Computational Neuroscience

    Is BTAI a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 10 BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q1 2024 Earnings Call Transcript
    May 10 BioXcel Therapeutics First Quarter 2024 Earnings: Misses Expectations
    May 10 Q1 2024 BioXcel Therapeutics Inc Earnings Call
    May 9 BioXcel Therapeutics, Inc. (BTAI) Q1 2024 Earnings Call Transcript
    May 9 BioXcel Therapeutics GAAP EPS of -$0.87 misses by $0.12, revenue of $0.58M misses by $0.05M
    May 9 BioXcel Therapeutics Reports First Quarter 2024 Financial Results
    May 8 BioXcel Therapeutics Q1 2024 Earnings Preview
    Apr 25 BioXcel Therapeutics to Report First Quarter 2024 Financial Results on May 9, 2024
    Apr 24 BioXcel Therapeutics Announces Late-Breaking Abstract on Preliminary Findings from Phase 2 Investigator-Sponsored Trial of BXCL701 and KEYTRUDA® in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) Selected for Presentation at 2024 ASCO Annual Meeting
    Apr 22 BioXcel Therapeutics Announces Plan for Evaluating BXCL501 in the At-Home Setting to Expand Its Market Potential
    See more BTAI news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 27.1
    52 Week Low 1.91
    Average Volume 534,800
    200-Day Moving Average 3.31
    50-Day Moving Average 2.62
    20-Day Moving Average 2.42
    10-Day Moving Average 2.19
    Average True Range 0.18
    RSI (14) 35.06
    ADX 15.37
    +DI 17.00
    -DI 24.37
    Chandelier Exit (Long, 3 ATRs) 2.49
    Chandelier Exit (Short, 3 ATRs) 2.60
    Upper Bollinger Bands 2.96
    Lower Bollinger Band 1.88
    Percent B (%b) 0.17
    BandWidth 44.76
    MACD Line -0.18
    MACD Signal Line -0.14
    MACD Histogram -0.0311
    Fundamentals Value
    Market Cap 62.89 Million
    Num Shares 30.4 Million
    EPS -7.36
    Price-to-Earnings (P/E) Ratio -0.28
    Price-to-Sales 92.61
    Price-to-Book 3.97
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.27
    Resistance 3 (R3) 2.28 2.24 2.23
    Resistance 2 (R2) 2.24 2.19 2.23 2.22
    Resistance 1 (R1) 2.15 2.16 2.13 2.14 2.21
    Pivot Point 2.11 2.11 2.10 2.10 2.11
    Support 1 (S1) 2.02 2.06 2.00 2.01 1.93
    Support 2 (S2) 1.98 2.03 1.97 1.92
    Support 3 (S3) 1.89 1.98 1.91
    Support 4 (S4) 1.88